Smells like a scandal to me, taking advantage of covid26 Nov 2020 11:44
2019-2020: The company focuses exclusively on drone operations and software in industrial use and keeps raising small sums from the market to expand its core business. Share price lingers mostly between 0.20-0.25 pence
January 2020: Enter Covid. Core business slows down.
17 July 2020: RMS raises £0.27 million by selling 106 million shares at 0.25p to investors. Braveheart Investment Group buys 80 million shares for £0.2 million. Shares at 0.28.
24 Aug 2020: RMS buys Pharm2Farm, a protective face mask maker in the process of working on a mask that can kill Covid on impact. Shares at 0.38.
From here on shares continue rising to 4.45 on 2 Nov.
05 Nov 2020: Pharm2Farm acquisition finalised. Braveheart Investment Group and RMS’s non-executive chairman Paul Ryan, a former Vodafone director, start selling their stakes. Shares at 2.65.
17 -18 Nov 2020: Braveheart and Ryan finalise the sale of their stakes. Braveheart sells 510 million shares for £17.16m, Paul Ryan sells a total of 70.7m shares for £2.93m.
https://www.thearmchairtrader.com/remote-monitored-systems-hangs-on-pharm2farm-thread/